TTP

TTP

Invention engine creating spin-out tech ventures

Overview

TTP develops new technologies and builds businesses from technical advances, acting as an invention engine in Cambridge. It prototypes innovations across life sciences, deep tech, and health tech, and often spins out successful ventures such as TTP Communications (2G/3G chipsets later sold to Motorola) and Cellular Origins (cell and gene therapy manufacturing, Series A $40M). The approach combines in-house invention and collaborative, employee-owned teams that tackle tough technical problems and move ideas toward markets. Its goal is to turn scientific breakthroughs into scalable products and companies that can grow globally, shaping technology ecosystems.

About TTP

Simplify's Rating
Why TTP is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consulting

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

United Kingdom

Founded

1987

Your Connections

People at TTP who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Miniaturized UAV satcom is moving from trials to commercial orders, creating near-term revenue from BVLOS demand.
  • Multi-vendor collaborations like Sat Companion accelerate adoption by leveraging ecosystem players like Qualcomm and Terrestar.
  • Software-defined, upgradeable 5G NTN modem architectures differentiate TTP by avoiding vendor lock-in for long-life terminals.

What critics are saying

  • Viasat's control of Gotonomi commoditizes TTP's low-SWaP terminal work and pushes pricing down within 6–12 months.
  • Qualcomm and Radisys' regenerative base-station push can displace TTP's stack-agnostic 5G NTN module within 12–18 months.
  • Exyte's acquisition of TTP Group siphons client relationships and compresses the addressable biopharma consulting niche within 12–24 months.

What makes TTP unique

  • TTP is an invention engine, not just a consultancy, with employees holding majority shares.
  • TTP created TTP Communications in 1988, powering 2G and 3G chip designs later acquired by Motorola.
  • TTP launched Cellular Origins in 2023, securing $40 million Series A funding for cell and gene therapy manufacturing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

Mental Health Support

Conference Attendance Budget

Professional Development Budget

Family Planning Benefits

Fertility Treatment Support

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Phone/Internet Stipend

Home Office Stipend

Hybrid Work Options

Paid Holidays

Paid Sick Leave

Parental Leave

Adoption Assistance

Childcare Support

Elder Care Support

Relocation Assistance

Employee Referral Bonus

Meal Benefits

Pet Insurance

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Gym Membership

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 2nd, 2025
Terrestar Solutions, Bittium, Ttp And Qualcomm Showcase The Sat Companion(Tm): Redefining Mobile Satellite Communications For A Connected World.

The Sat Companion prototype will be showcased at Mobile World Congress 2025 in Barcelona, Spain, on March 3–6. Visit us at the Finland Pavilion, Hall 5, Stand 5J45.MONTREAL, Feb. 26, 2025 /PRNewswire/ - Terrestar Solutions, in collaboration with Bittium, TTP plc and Qualcomm Technologies, Inc., introduces the Sat Companion, a next-gen device that enables direct-to-mobile satellite communications on any smartphone, anywhere. With its easy snap-on feature, patent-pending high-gain antenna and powered by the Qualcomm® 9205S Modem, the Sat Companion ensures seamless connectivity, providing users with uninterrupted SMS, chat, voice, and email services even in the most remote areas. Through Terrestar's leadership and the collaborative efforts of its trusted partners—Bittium, TTP, and Qualcomm Technologies—a new generation of high-performance devices is emerging. Together, these telecom leaders bring critical expertise and groundbreaking innovation to bridge cellular gaps and redefine connectivity, ensuring true and dependable mobile satellite communications across Canada and around the world

California Newswire
Oct 15th, 2024
Promising Neurotechnology Startups To Present At The 24Th Neurotech Leaders Forum

SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.Image caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum.Also presenting for the first time will be Katya Sverdlov, CEO and co-founder of JelikaLite, a clinical stage medtech company focused on the treatment of autism. Another new presenter is Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain.Other entrepreneur presenters at this year’s conference include Emily Mirro, President of SynchNeuro Inc., Andy Gotshalk, CEO, Neurologic Solutions, Luca Ravagnan, CEO of Italian firm WISE srl, Kial Gramley of BackStop Neural, and Imanuel Lerman, CEO, InflammaSense, Inc.Raymond Cohen, CEO of Axonics Inc., will keynote the 24th annual event—the most established in the industry. Mr. Cohen has served as CEO and member of the board of directors of Axonics since co-founding the company in October 2013

Bionity
Sep 10th, 2024
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business.

Techseriesinsight
Sep 5th, 2024
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business.

Business Wire
Jan 25th, 2024
Cellular Origins, a TTP Company, Appoints Peter Crossley as Chief Operating Officer

Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer.

Recently Posted Jobs

Sign up to get curated job recommendations

TTP is Hiring for 12 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →